Schultz to head CDRH for rest of 2004?
This article was originally published in The Gray Sheet
Executive Summary
Device center medical deputy post unlikely to be filled until CDRH obtains a permanent director, according to FDA staff. The agency had previously suggested that a medical deputy appointment was imminent, and that more than 20 candidates were under review (1"The Gray Sheet" April 19, 2004, p. 3). With the April 30 departure of former CDRH director David Feigal, however, staffers say Dan Schultz could remain acting director through the November elections...
You may also be interested in...
CDRH Leadership Changes May Be Imminent; NCI’s Ellen Feigal To Leave Institute
FDA is vetting a list of more than 20 candidates for a CDRH clinical deputy spot - a position that may grow in stature with the potential departure of Director David Feigal
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.
Probiotics And Cold Remedies Boost Recordati In 2023
Italy's Recordati saw its OTC sales grow by 10% in 2023 driven by the recovery of the cough & cold market and a growing demand for probiotics.